Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration.
2017-12-11

2017. Yeh ES, Williams CJ, Williams CB, Bonilla IV, Klauber-DeMore N, Phillips SL. Oncotarget 8(65): 109358-109369.